Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies. (Q54005683)
Jump to navigation
Jump to search
scientific article published in May 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies. |
scientific article published in May 2001 |
Statements
Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies. (English)
Treon SP
Mitsiades C
Mitsiades N
Young G
Doss D
Schlossman R
Anderson KC
1 May 2001
24
3
263-271